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Most hospital-acquired bloodstream infections are
associated with use of an intravascular device, specifically
central venous catheters. Catheter-associated bloodstream
infections occur more often in intensive care unit (ICU)
patients than in ward patients. The attributable mortality
rate for bloodstream infections in surgical ICUs has been
estimated to be 35% (1). ICU-acquired bloodstream infections
account for an estimated $40,000 increase in costs per survivor
and an estimated $6,000 increase in hospital costs (2).
In 1997, the Centers for Disease Control and Prevention’s
(CDC) National Nosocomial Infections Surveillance System
reported 0.4 to 9.2 bloodstream infections per 1,000 central-
line days in patients in surgical ICUs. A mean of 5.1 and a
median of 3.6 infections per 1,000 patient days was reported.
Coagulase-negative staphylococcus was found to be the
predominant microorganism responsible. In 1997, despite
conventional infection prevention and control strategies, we
identified a mean of 8.8 and a median of 8.9 catheter-
associated bloodstream infections per 1,000 patient days in
patients in a surgical ICU at Texas Medical Center. The
predominant microorganism responsible for these catheter-
associated bloodstream infections was coagulase-negative
staphylococcus, which has been associated with a lower risk of
death than other hospital-acquired bloodstream pathogens.
The Study
The Methodist Hospital, a tertiary-care facility in the
Texas Medical Center with 900 beds, is affiliated with Baylor
College of Medicine. The increased incidence of catheter-
associated bloodstream infections was identified in a 32-bed
surgical ICU. Prospective surveillance for device-related
infection is performed in the surgical ICU by an experienced
nurse epidemiologist. All positive cultures are reported to
infection control by the microbiology laboratory. CDC’s
definition for catheter-associated bloodstream infection is
used (3).
In response to the increased rate of infections, three
working groups were formed to develop strategies for catheter
selection, insertion, care, and maintenance; and clinical
practice guidelines. Products and practices used in the ICU
were reviewed, and a literature search was performed to
identify best practices associated with insertion, care, and
maintenance of central venous catheters, which formed the
basis for the clinical practice guidelines. The Design,
Measure, Assess, Improve model described by the Joint
Commission on Accreditation of Healthcare Organizations
was used to guide the plan of action (Figure).
The following recommendations were adopted by the
Infection Prevention and Control Committee: use an
antibiotic-coated catheter for patients expected to have the
device in place for >7 days; disseminate the clinical practice
guideline to surgeons, anesthesiologists, house staff, and
nursing staff; dispense maximum barrier precaution supplies
(i.e., gown, mask, gloves, and fenestrated drape with insertion
tray); and hire a vascular catheter-care nurse for the surgical
ICU. The nurse’s responsibilities would include educating the
house staff and nursing staff on the clinical practice
guideline; observing practices associated with insertion, care,
and maintenance of the central venous catheter system on all
three shifts; collecting and analyzing outcome data related to
bloodstream infections; and providing status reports to the
nursing staff, medical staff, and the Infection Prevention and
Control Committee.
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In a surgical intensive care unit, the 1996-1997 incidence of central catheter-associated bloodstream
infections exceeded that of hospitals participating in the National Nosocomial Infections Surveillance
System. Interventions were implemented, and a cost-benefit analysis was done that led to hiring a vascular
catheter care nurse. Subsequent outcome data demonstrated a substantial reduction in central catheter-
associated bloodstream infections.
Figure. Performance improvement model described by the Joint
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Table. Catheter-associated bloodstream infections per 1,000 central-
line days, surgical ICU, Texas
Year Mean Median
1977 8.8 8.9
1998 7.3 7.4
1999 6.6 6.7
Cost Analysis
A cost-benefit analysis was presented to the hospital
administration to justify hiring the nurse, at a projected
salary of $50,000. A cost of $6,000 per catheter-associated
bloodstream infections was used. We proposed that adding
the nurse to the staff would prevent at least one bloodstream
infection per month, or 12 infections annually. This cost-
benefit analysis approach was effective in securing approval
for the position. A registered nurse with 15 years of surgical
ICU experience at Methodist Hospital was hired in March
1999.
In January 2000, 9 months after joining the infection
control team, the nurse reported that 18 fewer bloodstream
infections occurred in 1999 than in 1998, for an estimated
savings of $108,000, with no change noted in surgical ICU
patient days. The 1999 mean bloodstream infection rate was
6.6 per 1,000 central-line days; the median was 6.7 per 1,000
central-line days (Table).
Conclusions
The pathogenesis of catheter-associated bloodstream
infections is multifactorial. A multidisciplinary approach is
necessary to develop and enforce corrective measures. Efforts
to prevent bloodstream infections in the surgical ICU patient
population are cost-effective from both the patient and
hospital standpoint. We were able to effectively present a
cost-benefit analysis to secure approval for a unique infection
prevention and control position.
In a cost-benefit analysis, the outcome is presented in
monetary terms (4). Another decision analysis tool, cost-
effectiveness analysis, incorporates both the cost and the
effect of the intervention. Cost-effectiveness analysis
measures the net cost of providing a service as well as the
outcome obtained. The outcomes are reported in a single unit
of measurement, e.g., years of life saved, number of lives
saved, or number of cases of a specific disease prevented (4,5).
The advantage of cost-effectiveness analysis is that it
considers the possibility of improved outcomes in exchange for
the use of more resources. A cost-effectiveness analysis is
planned to further justify the resource allocation of an ICU
nurse to the position of vascular catheter-care nurse.
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